Northern Survey on Therapeutic Oxygen Prescription

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03937622

Acronym

NONSTOP

Enrollment

500

Registered

2019-05-06

Start date

2019-07-02

Completion date

2021-09-20

Last updated

2019-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxygen Toxicity

Brief summary

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardized questionnaire.

Interventions

OTHER17 items questionaire

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardised questionnaire.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with chronic lung disease, age \> 18 years * Established domiciliary LTOT \> 4 weeks * Scheduled for control of oxygen therapy with arterial/capillary

Exclusion criteria

* No informed consent * Pulmonary exacerbation within the last 2 weeks * Signs of heart failure (edema, congestion)

Design outcomes

Primary

Measure	Time frame	Description
Validation of indication of Long-term Oxygen therapy (LTOT)	12 month	Aim of this study is to observe the real-world handling with longterm Oxygen treatment in northern Germany

Countries

Germany

Contacts

Primary ContactThomas Fühner, PD Dr. med.

fühner.thomas@mh-hannover.de+49 531595

Backup ContactHeiko Golpon, PD Dr. med.

golpon.heiko@mh-hannover.de+49 511 532

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026